BC3 Technologies Secures FDA Clearance and Launches Sprayable Bandage Product
BC3 Technologies, Inc. received FDA clearance for their SEAL Hemostatic Wound Spray in February, and has since announced their plans to launch their product.
The privately held medical device company operates with the mission to change the way health care professionals and first responders manage life-threatening arterial bleeding. Each year, 40 percent of critically wounded people with arterial bleeding die in transit to the hospital. Pressure and bandages can only do so much to help when managing a bleeding wound.
The sprayable bandage is designed with an aerosol can using chitosan to speed up blood clotting and seal up a wound. The spray forms a strong barrier over the wound, offering a painless method of halting the bleeding. The product was formulated for emergency situations, surgical environments, and for the battlefield where response time to hemorrhaging is the critical difference between life and death.
The company has performed studies, finding their formulation performed better than other chitosan-based products designed to reduce hemorrhage. Use of SEAL resulted in 50 percent less blood loss than other chitosan-based dressings or granules. Its proprietary aerosol delivery system – unique in the class – helps to stop the bleeding rapidly and effectively, and it reduces the risk of wound infections by preventing the growth of harmful bacteria. This novel spray design also allows the product to be applied directly to complex 3D wound architectures and forced into openings like gunshot wounds. This makes it more effective in reaching all aspects of the wound.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.